Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma

Although hotspot mutations in isocitrate dehydrogenase (IDH) genes are associated with favorable clinical outcomes in glioma, CDKN2A/B homozygous deletion has been identified as an independent predicator of poor prognosis. Accordingly, the 2021 edition of the World Health Organization (WHO) classifi...

Descripción completa

Detalles Bibliográficos
Autor principal: Huang, L. Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869746/
https://www.ncbi.nlm.nih.gov/pubmed/35203456
http://dx.doi.org/10.3390/biomedicines10020246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869746/
https://www.ncbi.nlm.nih.gov/pubmed/35203456
http://dx.doi.org/10.3390/biomedicines10020246

Ejemplares similares